Fulgent Genetics, Inc. (FLGT) › Cost of RevenueFulgent Genetics, Inc. (FLGT) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2014: $936.0K2015: $5.07M2016: $6.72M2017: $8.55M2018: $10.70M2019: $14.11M2020: $89.81M2021: $215.53M2022: $252.07M2023: $184.76M2024: $176.25M2025: $191.80M$191.80M2014Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$191.80M+8.8%2024$176.25M-4.6%2023$184.76M-26.7%2022$252.07M+17.0%2021$215.53M+140.0%2020$89.81M+536.6%2019$14.11M+31.9%2018$10.70M+25.1%2017$8.55M+27.2%2016$6.72M+32.6%2015$5.07M+441.6%2014$936.0K—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share